Document is current
Any future updates will be listed below
-
Authors
Scussel, Alice https://orcid.org/0009-0008-5729-8019
Rodrigues, Nathalia Galvagni
Santos, Artur Zanelatto
Trombin, Laura Corrêa de Barros
Pinto, Amanda Calage
Wagner, Litiele Evelin
Knorst, Marli Maria
Dean, James
Singh, Dave
Berton, Danilo Cortozi
-
Funding
Funding for this research was provided by:
Universidade Federal Do Rio Grande Do Sul
- License Information
-
More Information
Article History
Received: 31 October 2025
Accepted: 10 April 2026
First Online: 6 June 2026
Declarations
:
: All authors declare that they have no conflict of interest. Dave Singh has received sponsorship to attend and speak at international meetings, honoraria for lecturing or attending advisory boards from the following companies: Adovate, Almirall, Anaveon, Apogee, Arcutis Biotherapeutics, Arrowhead, AstraZeneca, Belenos Biosciences, Bial, Celldex, Chiesi, Cipla, CONNECT Biopharm, Covis, DevPro Biopharma LCC, Elpen, Empirico, EpiEndo, Generate Biomedicines, GlaxoSmithKline, Glenmark, Jasper, Kinaset Therapeutics, KOLON, Kymera, Lupin, Melodia, Menarini, MicroA, OM Pharma, OrientEuroPharma, Recipharm, Revolo, RIGImmune Inc, Roche, Roivant Sciences, Sanofi, Sitryx, Synairgen, Tetherex, UCB, Upstream, Verona Pharma, Winward, Zura Bio, Zymeworks. Danilo Berton has received honoraria for lecturing from the following companies: Chiesi, GlaxoSmithKline.
